A High-Throughput Fluorescence Polarization Assay for Inhibitors of Gyrase B

作者：Glaser Bryan T; Malerich Jeremiah P; Duellman Sarah J; Fong Julie; Hutson Christopher; Fine Richard M; Keblansky Boris; Tanga Mary J; Madrid Peter B^*

来源：Journal of Biomolecular Screening, 2011, 16(2): 230-238.

DOI：10.1177/1087057110392038

• fluorescence polarization
• gyrase
• assay development
• high-throughput screen
• anthracycline

DNA gyrase, a type II topoisomerase that introduces negative supercoils into DNA, is a validated antibacterial drug target. The holoenzyme is composed of 2 subunits, gyrase A (GyrA) and gyrase B (GyrB), which form a functional A(2)B(2) heterotetramer required for bacterial viability. A novel fluorescence polarization (FP) assay has been developed and optimized to detect inhibitors that bind to the adenosine triphosphate (ATP) binding domain of GyrB. Guided by the crystal structure of the natural product novobiocin bound to GyrB, a novel novobiocin-Texas Red probe (Novo-TRX) was designed and synthesized for use in a high-throughput FP assay. The binding kinetics of the interaction of Novo-TRX with GyrB from Francisella tularensis has been characterized, as well as the effect of common buffer additives on the interaction. The assay was developed into a 21-mu L, 384-well assay format and has been validated for use in high-throughput screening against a collection of Food and Drug Administration-approved compounds. The assay performed with an average Z' factor of 0.80 and was able to identify GyrB inhibitors from a screening library. (Journal of Biomolecular Screening 2011;16:230-238)

• 出版日期2011-2